IN THE NEWS
KQED RADIO INTERVIEW
Steve Pantilat interviewed on chemotherapy given to terminal cancer patients who aren’t expected to live beyond six months may do more harm than good. They discuss the pros and cons of chemotherapy for terminal patients, especially when weighed against the effects on quality of life. We’ll also look at the high rate of intensive treatments used in the final months for teens dying of cancer.
YOUR CALL WITH SANDIP ROY
On the next Your Call we'll have a conversation about palliative care and hospice care and the future of these services. In light of the federal health reform bill, what options are there for people to live through potentially fatal illness in a dignified, supported way? How do you envision being cared for as you near the end of your life? It's Your Call, with Sandip Roy and you.